wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38379672-BB330C33-8754-4916-A2EA-8153F0D6FE36
Q38379672-BB330C33-8754-4916-A2EA-8153F0D6FE36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38379672-BB330C33-8754-4916-A2EA-8153F0D6FE36
Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.
P2860
Q38379672-BB330C33-8754-4916-A2EA-8153F0D6FE36
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38379672-BB330C33-8754-4916-A2EA-8153F0D6FE36
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77d26f34c7d46ebe8294983a70060039fa45f8a0
P2860
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.